ALLIANCEBERNSTEIN L.P. 13D and 13G filings for Coherus BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:00 pm Sale |
2024-02-14 | 13G | Coherus BioSciences, Inc. CHRS |
ALLIANCEBERNSTEIN L.P. | 156,000 0.100% |
-6,023,005 (-97.48%) |
Filing |
| 2023-02-13 7:15 pm Purchase |
2023-02-14 | 13G | Coherus BioSciences, Inc. CHRS |
ALLIANCEBERNSTEIN L.P. | 6,179,005 8.000% |
510,477 (+9.01%) |
Filing |
| 2022-02-14 2:45 pm Purchase |
2022-02-14 | 13G | Coherus BioSciences, Inc. CHRS |
ALLIANCEBERNSTEIN L.P. | 5,668,528 7.400% |
1,012,629 (+21.75%) |
Filing |
| 2021-02-05 6:23 pm Purchase |
2021-02-15 | 13G | Coherus BioSciences, Inc. CHRS |
ALLIANCEBERNSTEIN L.P. | 4,655,899 6.500% |
4,655,899 (New Position) |
Filing |